Takeda Pharmaceutical Co Ltd (4502)

25.5500 -0.3500 (-1.35%)
Delayed Data EUR Disclaimer

Takeda Pharmaceutical Co Ltd Company Profile

Equity Type
Takeda Pharmaceutical Company Limited engages in the research, development, manufacturing, marketing, and out-licensing of pharmaceutical products worldwide. It offers pharmaceutical products in the areas of gastroenterology; oncology; neuroscience; and rare diseases, such as rare metabolic and hematology, and heredity angioedema, as well as plasma-derived therapies and vaccines. The company provides its products under the Entyvio, Gattex/Revestive, Alofisel, Natpara, Adynovate/Adynovi, Takhzyro, Elaprase, Vpriv, Gammagard Liquid/Kiovig, Hyqvia, Cuvitru, Albumin/Flexbumin, Ninlaro, and Alunbrig brands. Takeda Pharmaceutical Company has licensing agreements with Denali Therapeutics and Wave Life Sciences Ltd; collaboration agreements with Neurocrine Biosciences, Inc. and Rani Therapeutics LLC; license and research agreements with The University of Texas MD Anderson Cancer Center, Poseida Therapeutics, Inc., and Arrowhead Pharmaceuticals Inc.; research collaboration agreements with Arrowhead Pharmaceuticals Inc. and Ovid Therapeutics Inc.; and collaboration with Evox Therapeutics Ltd., as well as a licensing agreement with ProThera Biologics Inc. It also has strategic alliances with Egle Therapeutics SAS; Evotec SE; Neurocrine Biosciences, Inc.; Carmine Therapeutics; HemoShear Therapeutics, LLC; KSQ Therapeutics; and Anima Biotech. Takeda Pharmaceutical Company Limited was founded in 1781 and is headquartered in Tokyo, Japan.
Contact Information
Tokyo,103-8668 Japan
81 3 3278 2111
81 3 3278 2000
Top Executives
Constantine Saroukos 50 2018 CFO & Representative Director
Christophe Weber 55 2014 President, CEO & Representative Director
Sidney Taurel 72 0000 Member of Takeda Global Advisory Board
Masahiro Sakane 80 2014 Independent Chairman of the Board
Steven S. Gillis 68 2019 Independent External Director
Yoshiaki Fujimori 70 2016 Independent External Director
Olivier Bohuon 62 2019 Independent External Director
Bruno Francois Jules Angelici 74 2010 Member of Takeda Global Advisory Board
Toshiyuki Shiga 68 2016 Independent External Director
Jean-Luc Butel 65 2019 Independent External Director
William W. Chin 0 0000 Member of Takeda Global Advisory Board
Masami Iijima 71 2021 Independent External Director
Shiro Kuniya 64 2013 Independent External Director
Ian T. Clark 61 2019 Independent External Director
Masato Iwasaki 63 2012 Representative Director
Koji Hatsukawa 70 2016 Independent External Director
Karen L. Katen 72 0000 Member of Takeda Global Advisory Board
Andrew S. Plump 56 2015 President of Research & Development and Representative Director
Michel Orsinger 64 2016 Independent External Director
Emiko Higashi 63 2016 Independent External Director
Clear All
Please try another search

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.